SEC Comment Letter 0000000000-24-009201 to Generation Bio Co. (GBIO) (CIK 0001733294)
Generation Bio Co. (GBIO) (CIK 0001733294)
Date: Aug. 12, 2024 · CIK: 0001733294 · Accession: 0000000000-24-009201
AI Filing Summary & Sentiment
File numbers found in text: 333-281335
Letter
August 12, 2024 Geoff McDonough, M.D. Chief Executive Officer Generation Bio Co. 301 Binney Street Cambridge, MA 02142 Re:Generation Bio Co. Registration Statement on Form S-3 Filed August 7, 2024 File No. 333-281335 Dear Geoff McDonough M.D.: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tyler Howes at 202-551-3370 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Molly W. Fox, Esq.
Show Raw Text
August 12, 2024
Geoff McDonough, M.D.
Chief Executive Officer
Generation Bio Co.
301 Binney Street
Cambridge, MA 02142
Re:Generation Bio Co.
Registration Statement on Form S-3
Filed August 7, 2024
File No. 333-281335
Dear Geoff McDonough M.D.:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that
the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tyler Howes at 202-551-3370 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Molly W. Fox, Esq.